Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes

We assessed the effect of the addition of pioglitazone on metabolic control and heart function of patients with type 2 diabetes already receiving sulfonylurea plus metformin. Forty-four patients were given 30 mg of pioglitazone for 3 months. Physical examination, laboratory tests including N-termina...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta diabetologica 2008-03, Vol.45 (1), p.23-30
Hauptverfasser:	Sambanis, Christos, Tziomalos, Konstantinos, Kountana, Evangelia, Kakavas, Nikitas, Zografou, Ioanna, Balaska, Aikaterini, Koulas, Georgios, Karagiannis, Asterios, Zamboulis, Chrysanthos
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Blood Glucose - drug effects Blood Glucose - metabolism C-Reactive Protein - metabolism Cardiovascular system Clinical outcomes Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - physiopathology Drug therapy Echocardiography Female Heart - drug effects Heart - physiopathology Humans Hypoglycemic Agents - therapeutic use Internal Medicine Lipids - blood Liver Function Tests Male Medicine Medicine & Public Health Metabolic Diseases Metabolism Metformin - therapeutic use Middle Aged Natriuretic Peptide, Brain Original Article Peptide Fragments Peptides Pharmacology Thiazolidinediones - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!